• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诺氟沙星对1700株相对耐药临床分离株的抗菌活性。

Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates.

作者信息

Qadri S M, Lee G, Brodie L

机构信息

King Faisal Specialist Hospital, Riyadh, Saudi Arabia.

出版信息

Drugs Exp Clin Res. 1989;15(8):349-53.

PMID:2598776
Abstract

A total of 1724 clinical isolates from patients with different infections were tested in vitro to determine their susceptibility to norfloxacin. Antibacterial activity of norfloxacin was compared with other drugs that were commonly used in the hospital. Of the 919 strains of Enterobacteriaceae tested, all except four isolates of Enterobacter, two of Serratia and one of Proteus were susceptible to norfloxacin. Ninety-five percent of the 199 strains of Pseudomonas aeruginosa were also inhibited by this quinolone. Brucella melitensis (81 strains) was completely susceptible to norfloxacin. All the 250 isolates of Staphylococcus aureus and coagulase-negative staphylococci were also sensitive to norfloxacin. Pseudomonads other than P.aeruginosa, Acinetobacter/Alcaligenes and group D streptococci were less sensitive to norfloxacin, with 56%, 57% and 20% respectively being inhibited by this antimicrobial agent.

摘要

对来自不同感染患者的1724株临床分离株进行了体外测试,以确定它们对诺氟沙星的敏感性。将诺氟沙星的抗菌活性与医院常用的其他药物进行了比较。在测试的919株肠杆菌科细菌中,除4株阴沟肠杆菌、2株沙雷氏菌和1株变形杆菌外,所有菌株均对诺氟沙星敏感。199株铜绿假单胞菌中,95%也受到这种喹诺酮类药物的抑制。羊布鲁氏菌(81株)对诺氟沙星完全敏感。所有250株金黄色葡萄球菌和凝固酶阴性葡萄球菌对诺氟沙星也敏感。除铜绿假单胞菌外的假单胞菌、不动杆菌/产碱杆菌和D组链球菌对诺氟沙星不太敏感, 分别有56%、57%和20%被这种抗菌剂抑制。

相似文献

1
Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates.诺氟沙星对1700株相对耐药临床分离株的抗菌活性。
Drugs Exp Clin Res. 1989;15(8):349-53.
2
[In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].诺氟沙星对近期临床分离的革兰氏阳性和革兰氏阴性菌的体外活性
Boll Ist Sieroter Milan. 1985;64(4):289-93.
3
Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.诺氟沙星及其他药物对耐阿莫西林尿路致病性分离株的体外活性研究。
Chemioterapia. 1984 Jun;3(3):167-72.
4
The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.革兰氏阴性菌和革兰氏阳性菌对氧氟沙星的敏感性。
Chemioterapia. 1987 Feb;6(1):17-22.
5
Antimicrobial activity of imipenem against 1386 clinical isolates.亚胺培南对1386株临床分离菌的抗菌活性。
Methods Find Exp Clin Pharmacol. 1986 Nov;8(11):675-8.
6
The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.革兰氏阴性菌和革兰氏阳性菌对氧氟沙星的敏感性。
Drugs Exp Clin Res. 1987;13(9):555-61.
7
Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.近期临床分离株对替马沙星(A-63004)及其他抗菌药物的敏感性。
Drugs Exp Clin Res. 1992;18(8):311-7.
8
[Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
Med Dosw Mikrobiol. 1993;45(1):115-8.
9
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.针对重症监护病房住院患者的医院内细菌病原体测试替加环素的抗菌活性。
Diagn Microbiol Infect Dis. 2005 Jul;52(3):203-8. doi: 10.1016/j.diagmicrobio.2005.05.002.
10
In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.莫西沙星对台湾常见临床分离菌株的体外活性。
J Microbiol Immunol Infect. 2001 Sep;34(3):178-84.

引用本文的文献

1
Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.喹诺酮类药物治疗人类布鲁氏菌病:微生物学和临床研究证据的批判性综述
Antimicrob Agents Chemother. 2006 Jan;50(1):22-33. doi: 10.1128/AAC.50.1.22-33.2006.